Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis
The Prostate · 2024
DOI: 10.1002/pros.24646 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Huajie Di und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Vasectomy, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
Previous reports have shown a potential causal impact of vasectomy on prostate cancer (PCa). The objective of this study was to investigate the association between vasectomy and PCa, while evaluating the influence of confounding factors such as prostate‐specific antigen (PSA) screening and body mass index (BMI).
Methods
Mendelian randomization (MR) study using summary statistics from genome‐wide associations of vasectomy (462,933 European ancestry), ever had PSA test (200,410 European ancestry), time since last PSA test (46,104 European ancestry), BMI (152,893 European males) and PCa (79,148 cases, 61,106 controls, European ancestry). This study was conducted using summary statistic data from large, previously described cohorts. Data analyses were conducted from November 2022 to June 2023.
Results
Genetic liability to vasectomy was not associated with PCa (OR = 0.07, 95% CI: 2.95 10 −3 , 1.54, p = 0.09). Genetic liability to vasectomy was not associated with ever had PSA test (OR = 1.08, 95% CI: 0.49−2.39, p = 0.83) and time since last PSA test (OR = 2.49, 95% CI: 0.71−8.79, p = 0.16). After controlling for PSA test and BMI, there remains no causal relationship between vasectomy and PCa risk (OR = 5.56 10 −4 , 95% CI: 7.29 10 −8 , 4.24, p = 0.10). The reverse MR results showed a weak association between PCa and vasectomy patients (OR = 1.00, 95% CI: 1.0003−1.0033, p = 0.02).
Conclusion
Based on the available evidence from MR analysis, the current findings did not support vasectomy being a risk factor for PCa. Further work is required to provide additional confirmation and validation of the potential link.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Xuzhou Medical University, Xuzhou, China.
- Evidence-based Medicine Research Center, Xuzhou Medical University, Xuzhou, China.
- Department of Pediatric Urology, The Affiliated Xuzhou Children's Hospital of Xuzhou Medical University, Xuzhou, China.
Zitieren
APA
Di, H., & Wen, Y. (2024). Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis. The Prostate. https://doi.org/10.1002/pros.24646
Vancouver
Di H, Wen Y. Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis. The Prostate. 2024. doi:10.1002/pros.24646
BibTeX
@article{Di2024,
author = {Di, Huajie and Wen, Yi},
title = {Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24646}
}
EUVIMED